0001640455-21-000029.txt : 20210203
0001640455-21-000029.hdr.sgml : 20210203
20210203174843
ACCESSION NUMBER: 0001640455-21-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210203
DATE AS OF CHANGE: 20210203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MURRAY RICHARD /CA/
CENTRAL INDEX KEY: 0001242935
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37998
FILM NUMBER: 21587572
MAIL ADDRESS:
STREET 1: 22643 WOODRIDGE CT
CITY: CUPERTINO
STATE: CA
ZIP: 95014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jounce Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640455
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 454870634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-3840
MAIL ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_161239250703335.xml
FORM 4
X0306
4
2021-02-01
0
0001640455
Jounce Therapeutics, Inc.
JNCE
0001242935
MURRAY RICHARD /CA/
C/O JOUNCE THERAPEUTICS, INC.
780 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
1
1
0
0
CEO and President
Common Stock
2021-02-01
4
A
0
75000
0
A
215371
D
Common Stock
2021-02-03
4
A
0
7500
0
A
222871
D
Stock Option (Right to Buy)
11.89
2021-02-01
4
A
0
150000
0
A
2031-02-01
Common Stock
150000.0
150000
D
Stock Option (Right to Buy)
12.67
2021-02-01
4
A
0
15000
0
A
2031-02-03
Common Stock
15000.0
15000
D
The option will vest quarterly in 16 equal installments following January 1, 2021.
/s/ Kim C. Drapkin, Attorney-in-Fact
2021-02-03